One can prefer Dr Reddys Laboratories, Sun Pharma over Ranbaxy, says Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities.
first published: May 14, 2013 03:54 pm
A collection of the most-viewed Moneycontrol videos.
LIVE: Global Markets Sell off Again | Weak start expected for Nifty | Gas supplies in focus
Iran Fires Missiles Across Middle East As Ships Hit In Gulf | Hormuz Crisis Deepens
PM Modi Speech: 5 Big Highlights You Can’t Miss | Congress Targeted, Gulf Nations Praised
ON CAM: Iran ‘BURNS’ Two Israeli Hermes Drones; IRGC Mocks IDF | Watch
